Antitrust Division: Second Pharmaceutical Company Admits to Price Fixing, Resolves Related False Claims Act Violations
December 03, 2019
December 03, 2019
WASHINGTON, Dec. 3 -- The U.S. Department of Justice's Antitrust Division issued the following news release:
* * *
- Rising Pharmaceuticals Agrees to Pay Over $3 Million in Criminal Penalty, Restitution, and Civil Damages
* * *
Rising Pharmaceuticals Inc. (Rising), a generic pharmaceutical company headquartered in New Jersey, was charged for conspiring to fix prices and allocate customers for a generic hypertension drug, the Department of . . .
* * *
- Rising Pharmaceuticals Agrees to Pay Over $3 Million in Criminal Penalty, Restitution, and Civil Damages
* * *
Rising Pharmaceuticals Inc. (Rising), a generic pharmaceutical company headquartered in New Jersey, was charged for conspiring to fix prices and allocate customers for a generic hypertension drug, the Department of . . .